Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, et al. Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial. J Clin Oncol. 2020;38(16):1763–73.
Article CAS PubMed PubMed Central Google Scholar
Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, et al. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. J Clin Oncol. 2022;40(11):1220–30.
Article CAS PubMed Google Scholar
Augustinus S, Schafrat PJM, Janssen BV, Bonsing BA, Brosens LAA, Busch OR, et al. Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer. Ann Surg Oncol. 2023;30(8):5051–60.
Article PubMed PubMed Central Google Scholar
Lee YS, Lee J-C, Yang SY, Kim J, Hwang J-H. Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis. Scientific reports. 2019;9(1):15662.
Article PubMed PubMed Central Google Scholar
Dhir M, Malhotra GK, Sohal DPS, Hein NA, Smith LM, O’Reilly EM, et al. Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients. World journal of surgical oncology. 2017;15(1):183.
Article PubMed PubMed Central Google Scholar
Strobel O, Hank T, Hinz U, Bergmann F, Schneider L, Springfeld C, et al. Pancreatic Cancer Surgery: The New R-status Counts. Annals of surgery. 2017;265(3):565–73.
Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al]. 2018;18(1):2–11.
Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15(6):1651–60.
Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014;155(6):977–88.
Safi SA, Haeberle L, Fluegen G, Lehwald-Tywuschik N, Krieg A, Keitel V, et al. Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al]. 2021.
Safi SA, David S, Haeberle L, Vaghiri S, Luedde T, Roderburg C, et al. Most oncological pancreas resections must consider the mesopancreas. BMC Cancer. 2025;25(1):200.
Article CAS PubMed PubMed Central Google Scholar
Testut L. Traite D‘ Anatomie Humaine. 1923.
Rouviere H. Anatomie Humaine Tome 1 Tete, cou et tronc. 1924.
Langer C. Lehrbuch der Anatomie des Menschen: Wilhelm Braumüller K. K. Hofbuchhaendler; 1865.
Fortner JG, Kim DK, Cubilla A, Turnbull A, Pahnke LD, Shils ME. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Annals of surgery. 1977;186(1):42–50.
Article CAS PubMed PubMed Central Google Scholar
Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. The British journal of surgery. 2004;91(5):586–94.
Article CAS PubMed Google Scholar
Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland. 2009;11(4):354–64; discussion 64 – 5.
Article CAS PubMed Google Scholar
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet (London, England). 1986;1(8496):1479–82.
Article CAS PubMed Google Scholar
McAnena OJ, Heald RJ, Lockhart-Mummery HE. Operative and functional results of total mesorectal excision with ultra-low anterior resection in the management of carcinoma of the lower one-third of the rectum. Surgery, gynecology & obstetrics. 1990;170(6):517–21.
Safi SA, Haeberle L, Rehders A, Fung S, Vaghiri S, Roderburg M, et al. Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer. Cancers. 2021.
Safi SA, Haeberle L, Heuveldop S, Kroepil P, Fung S, Rehders A, et al. Pre-Operative MDCT Staging Predicts Mesopancreatic Fat Infiltration-A Novel Marker for Neoadjuvant Treatment? Cancers. 2021;13(17).
Navez J, Pezzullo M, Bouchart C, Arsenijevic T, Demetter P, Closset J, et al. Impact of the radiological morphology of the mesopancreas on the outcome after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: retrospective study. BJS Open. 2024;8(6).
Wellner UF, Krauss T, Csanadi A, Lapshyn H, Bolm L, Timme S, et al. Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective Study. Medicine (Baltimore). 2016;95(3):e2529.
Article PubMed PubMed Central Google Scholar
Kimura W. Surgical anatomy of the pancreas for limited resection. Journal of hepato-biliary-pancreatic surgery. 2000;7(5):473–9.
Article CAS PubMed Google Scholar
Häberle L, Esposito I. Circumferential resection margin (CRM) in pancreatic cancer. Surgery in Practice and Science. 2020;1:100006.
Haeberle L, Esposito I. Pathology of pancreatic cancer. Translational gastroenterology and hepatology. 2019;4:50.
Article PubMed PubMed Central Google Scholar
Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS. Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB: the official journal of the International Hepato Pancreato Biliary Association. 2009;11(1):18–24.
Article PubMed PubMed Central Google Scholar
Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. The British journal of surgery. 2006;93(10):1232–7.
Article CAS PubMed Google Scholar
Safi SA, Alexander A, Neuhuber W, Haeberle L, Rehders A, Luedde T, et al. Defining distal splenopancreatectomy by the mesopancreas. Langenbecks Arch Surg. 2024;409(1):127.
Article PubMed PubMed Central Google Scholar
Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, et al. Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study. J Clin Oncol. 2023;41(24):4025–34.
Article CAS PubMed Google Scholar
Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253(4):711–9.
Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL, et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023;389(4):322–34.
Article CAS PubMed PubMed Central Google Scholar
Matsumoto S, Mori H, Kiyonaga M, Sai M, Yamada Y, Hijiya N, et al. “Peripancreatic strands appearance” in pancreatic body and tail carcinoma: evaluation by multi-detector CT with pathological correlation. Abdominal Imaging. 2012;37(4):602–8.
Endo Y, Noda H, Iseki M, Aizawa H, Inoue K, Maeda S, et al. Thick mesopancreas is a novel predictor of surgical outcomes of patients who undergo pancreaticoduodenectomy. Langenbeck’s archives of surgery. 2024;409(1):181.
Comments (0)